Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antimitotic amides for the treatment of cancer and proliferative disorders

Antimitotic amides for the treatment of cancer and proliferative disorders

US Patent 12383533 · Granted Aug 12, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Alvocidib prodrugs having increased bioavailability2025
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer2024
ALK-5 inhibitors and uses thereof2023
Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof2022
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer2022
Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the2022
Formulations comprising heterocyclic protein kinase inhibitors2022
AXL kinase inhibitors and use of the same2022
Alvocidib prodrugs and their use as protein kinase inhibitors2022
Antimitotic amides for the treatment of cancer and proliferative disorders2021
Methods for treating diseases associated with abnormal ACVR1 expression and ACVR2021
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer2021